CAS: 13515-97-4; H-Dl-Ala-Ome.Hcl

该化合物是丙烯甲基酯盐化物的一种种族混合物,通常用于peptide合成和生化研究,该化合物是将残留物引入peptide链的多用途构件,而甲基酯组则促进混合反应.盐能增强水溶剂和有机溶剂的稳定性和溶性,使之适合一系列试验条件.其种族形式(DL)允许在L-和D-alaynine衍生物研究中应用.该产品具有高纯度和一贯性能,确保合成和分析工作流程的可靠结果.建议在无水条件下适当储存以保持完整性.

结构式图片

相似化合物

14316-06-4 2491-20-5 28819-05-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

methanol rac-Ala-OH methyl-malonic acid-monoazide methyl 2-{[(tert-butoxy)carbonyl]amino}propanoateN-(N-benzoyl-glycyl)-alanine methyl esterN-(N-benzoyl-glycyl)-alanine methyl ester 2-chloro-propionic acid methyl ester methyl lactate N-benzyloxycarbonyl-glycyl=>glycyl=>-alanine methyl esterN-benzyloxycarbonyl-glycyl=glycyl=-alanine methyl ester

合成工艺路线路线简述

    L-丙氨酸 以 甲醇 用作溶剂,化学反应生成Dl-丙氨酸甲酯盐酸盐
    参考文献:Arylsulfonamido-Substituted Hydroxamic Acids
    标题:Arylsulfonamido-Substituted Hydroxamic Acids
    摘要:该发明涉及公式i的化合物,其药学上可接受的前药衍生物和药学上可接受的盐;其制备方法;包含所述化合物的药物组合物;以及使用这些化合物抑制基质降解金属蛋白酶并治疗依赖于基质降解金属蛋白酶的哺乳动物疾病的方法.

    海关参考信息

    专利信息


    专利号:US-12247037-B2
    优先权日:2018-12-12
    标题:1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders
    发明人:BRANDT GARY
    权利人:NEUMORA THERAPEUTICS INC
    摘要:The present invention relates to 1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine derivatives and related compounds of Formula (I): wherein A, B, G, R1, R1b, RiC, R2 and X are as defined herein. The present compounds are vasopressin receptor antagonists (in particular of the Via receptor) for the treatment of neuro-psychological disorders, such as e.g. autism, anxiety, stress-related disorders, depression, schizophrenia or bipolar disorder. The present description discloses the synthesis of exemplary compounds, as well as pharmacological data thereof (e.g. pages 71 to 246; examples 1 to 49; tables 1 to 5). An exemplary compound is e.g. 8-chloro-1-(2-(5-fluoropyridin-2-yl)-2,6-diazaspiro[3.3]heptan-6-yl)-5-methyl-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (example 1, compound no. 1).

    专利号:US-2009275727-A1
    优先权日:1998-03-24
    标题:Peptide turn mimetics
    发明人:CASSIDY PETER J; ALEWOOD PAUL FRANCIS; VERNALL ANDREA JOY
    权利人:MIMETICA PTY LTD
    摘要:This invention provides novel compounds useful for the synthesis of peptide mimetics, and describes the use of these compounds for the synthesis of novel reverse turn mimetics. The reverse turn mimetics of the invention have the general structure X wherein the variables are as defined herein.

    专利号:US-2012190648-A1
    优先权日:2009-07-23
    标 题:Fluorinated cyclopropane analogs of glutamic acid
    发明人:JUBAULT PHILIPPE; QUIRION JEAN-CHARLES; LEMONNIER GERALD; LION CEDRIC
    权利人:JUBAULT PHILIPPE; QUIRION JEAN-CHARLES; LEMONNIER GERALD; LION CEDRIC
    摘要:The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a mixture in all proportions of stereoisomers thereof, in particular a mixture of enantiomers, such as a racemic mixture, wherein R represents a (C 1 -C 6 )alkyl or (C 1 -C 6 )alkenyl group, optionally substituted by one or more groups chosen among an halogen atom, OR a , SR b , NR c R d , PO(OR e )(OR f ), CO 2 R g , SO 2 R h SO 3 R 1 , P0(0H)(CH(0H)R k ), CN, N 3 and NH—C(â•?NH)NH2, with R a , R b , R c and R d , representing, independently of each other, an hydrogen atom, a (C 1 -C 6 )alkyl group or a —CO—(C 1 -C 6 )alkyl group, R e , R f , R g , R h and R1 representing, independently of each other, an hydrogen atom or a (C 1 -C 6 )alkyl group, and R k representing an aryl or heteroaryl group, said group being optionally substituted by one or more groups selected from an halogen atom and NO 2 , as well as to the use thereof and to a process for preparing such a compound, to a pharmaceutical composition containing it and to synthesis intermediates.

    专利号:US-9351974-B2
    优先权日:2011-11-10
    标题 :Substituted pteridinones for the treatment of cancer
    发明人:JIN MEIZHONG; KADALBAJOO MRIDULA; LI AN-HU; MULVIHILL MARK J; SIU KAM W; STEINIG ARNO G; WANG JING
    权利人:OSI PHARMACEUTICALS LLC
    摘要:Compounds of Formula I, as shown below and defined herein: n npharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven or mediated at least in part by RSK. This Abstract is not limiting of the invention.

    专利号:US-8518885-B2
    优先权日:2008-02-06
    标题 :Heterocyclic peptide ketoamides
    发明人:POWERS JAMES C; GLASS JONATHAN D; OVAT ASLI; LI ZHAOZHAO
    权利人:POWERS JAMES C; GLASS JONATHAN D; OVAT ASLI; LI ZHAOZHAO; GEORGIA TECH RES INST; UNIV EMORY
    摘要:A novel class of peptide α-ketoamides useful for selectively inhibiting calpains, selectively inhibiting cysteine proteases, and generally inhibiting all cysteine proteases, having the formula M-AA 2 -AA 1 -CO—NH—(CH 2 ) n —R 3 . Processes for the synthesis of peptidyl α-ketoamide derivatives. Compositions and methods for inhibiting cysteine proteases, inhibiting calpains, and treating disease caused by cysteine proteases and calpains are provided.

    专利号:CN-113893825-B
    优先权日:2021-10-27
    标 题 :Synthesis of Alanine Bioskeleton Porous Silicon Materials
    上海福之晟生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fzsbio.com
    企业联系电话:18049930630,15722522399👤
    📞上海福之晟生物科技有限公司 ⚠️参考联系方式
    联系人:杨鹏;卞钰麟
    电话:18049930630,15722522399
    手机:杨鹏18049930630;卞钰麟15722522399
    传真:QQ:875507263
    邮箱:yangpeng@fzsbio.com;bianyulin@fzsbio.com
    通信地址: 上海奉贤区南桥镇杨海路666号
    邮编: 201499
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海奉贤区南桥镇杨海路666号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:1,1-Dioxonaphtho[1,2-B]Thiophene-2-Methyloxycarbonyl (α-Nsmoc) And 3,3-Dioxonaphtho[2,1-B]Thiophene-2-Methyloxycarbonyl (β-Nsmoc) Amino-Protecting Groups
    作者:Louis A. Carpino,Adel Ali Abdel-Maksoud,Dumitru Ionescu,E. M. E. Mansour,Mohamed A. Zewail |发布日期:2007.3.1
    摘要:Mechanistically Similar To That Previously Established For The Bsmoc Derivative In That The Reaction Is Initiated By Michael Addition To The β-Carbon Atom Of The α,β-Unsaturated Sulfone System. Application Of α- And β-Nsmoc Amino Acids To The Solid-Phase Synthesis Of Two Model Peptides Was Examined. An Advantage Of The α-Nsmoc System Over The Long-Known Bsmoc System Proved To Be The Milder Conditions Needed For

    合成参考文献


    摘要:Liao, L.; Zhang, Y.; Yu, J.-S., Science of Synthesis: Knowledge Updates, (2024) 1, 236.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知